ifn γ e el h0108 levels (Elabscience Biotechnology)
Elabscience Biotechnology is a verified supplier 
Elabscience Biotechnology manufactures this product 
95
Structured Review
Elabscience Biotechnology
ifn γ e el h0108 levels
Ifn γ E El H0108 Levels, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 161 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+ifn+%CE%B3+elisa+kit/Human+IFN-%CE%B3+(Interferon+Gamma)+ELISA+Kit/10__5114_slash_ceji_slash_222384-130-11-18
Average 95 stars, based on 161 article reviews
Ifn γ E El H0108 Levels, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 161 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+ifn+%CE%B3+elisa+kit/Human+IFN-%CE%B3+(Interferon+Gamma)+ELISA+Kit/10__5114_slash_ceji_slash_222384-130-11-18
Average 95 stars, based on 161 article reviews
ifn γ e el h0108 levels - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Enzyme-linked Immunosorbent Assay:Article Title: Elevated IgG levels induce an M2‑to‑M1 phenotypic shift in mucosal macrophages and restrict the growth of invasive sphenoid sinus pituitary adenomas. Article Snippet: .. Article Title: Multiomics profiling Identifies MCMBP as a prognostic biomarker and a potential immune-related target in pancreatic ductal adenocarcinoma via the JAK–STAT3 pathway Article Snippet: After a 2 hour stabilization period, T-cell activation was induced by adding soluble anti-CD3 antibody (2μg/mL, Elabscience, Wuhan, CN), soluble anti-CD28 antibody (1μg/mL, Elabscience, Wuhan, CN), and Goat Anti-Mouse IgG (5μg/mL, Elabscience, Wuhan, CN) to the culture medium. .. Following 24 hours of activation, the cell culture supernatant was collected, and the concentration of secreted IFN-γ was quantified using a Article Title: Knockdown of PELI1 promotes Th2 and Treg cell differentiation in juvenile idiopathic arthritis. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Article Title: GB20-5A8-31, an anti-TL1A antibody for treating inflammatory bowel disease Article Snippet: .. And the IFN-γ levels were quantified using a Article Title: SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2 Article Snippet: .. The cell culture medium of the co-culture system of CC cells and immune cells, or the medium of CC cells alone, was collected and centrifuged at 4 °C, 1000 × g for 20 min. Cytokine levels in the supernatant were detected by Article Title: Lidocaine Modulates Cytokine Production and Reprograms the Tumor Immune Microenvironment to Enhance Anti-Tumor Immune Responses in Gastric Cancer Article Snippet: .. The production of IFN-γ, IL-12, IL-10, and TGF-β was analyzed by the human IL-10 ELISA kit (Arigo Biolaboratories, Taipei, Taiwan), human IL-12, TGF-β ELISA kit (Elabscience, Houston, TX, USA), and Article Title: Chrysin Enhances Anti-Cancer Activity of Jurkat T Cell and NK-92 Cells Against Human Breast Cancer Cell Lines. Article Snippet: Chrysin, a naturally occurring flavonoid in plant and bee products, demonstrates notable biological activities, including anti-cancer effects.. These properties are partially attributed to its capability to activate immune cells.. This study focused on exploring the immunomodulatory potential of chrysin on NK-92 and Jurkat-T cells targeting breast cancer cells (BCC). Article Title: Elevated IgG levels induce an M2-to-M1 phenotypic shift in mucosal macrophages and restrict the growth of invasive sphenoid sinus pituitary adenomas Article Snippet: .. Activation Assay:Article Title: Multiomics profiling Identifies MCMBP as a prognostic biomarker and a potential immune-related target in pancreatic ductal adenocarcinoma via the JAK–STAT3 pathway Article Snippet: After a 2 hour stabilization period, T-cell activation was induced by adding soluble anti-CD3 antibody (2μg/mL, Elabscience, Wuhan, CN), soluble anti-CD28 antibody (1μg/mL, Elabscience, Wuhan, CN), and Goat Anti-Mouse IgG (5μg/mL, Elabscience, Wuhan, CN) to the culture medium. .. Following 24 hours of activation, the cell culture supernatant was collected, and the concentration of secreted IFN-γ was quantified using a Cell Culture:Article Title: Multiomics profiling Identifies MCMBP as a prognostic biomarker and a potential immune-related target in pancreatic ductal adenocarcinoma via the JAK–STAT3 pathway Article Snippet: After a 2 hour stabilization period, T-cell activation was induced by adding soluble anti-CD3 antibody (2μg/mL, Elabscience, Wuhan, CN), soluble anti-CD28 antibody (1μg/mL, Elabscience, Wuhan, CN), and Goat Anti-Mouse IgG (5μg/mL, Elabscience, Wuhan, CN) to the culture medium. .. Following 24 hours of activation, the cell culture supernatant was collected, and the concentration of secreted IFN-γ was quantified using a Article Title: SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2 Article Snippet: .. The cell culture medium of the co-culture system of CC cells and immune cells, or the medium of CC cells alone, was collected and centrifuged at 4 °C, 1000 × g for 20 min. Cytokine levels in the supernatant were detected by Concentration Assay:Article Title: Multiomics profiling Identifies MCMBP as a prognostic biomarker and a potential immune-related target in pancreatic ductal adenocarcinoma via the JAK–STAT3 pathway Article Snippet: After a 2 hour stabilization period, T-cell activation was induced by adding soluble anti-CD3 antibody (2μg/mL, Elabscience, Wuhan, CN), soluble anti-CD28 antibody (1μg/mL, Elabscience, Wuhan, CN), and Goat Anti-Mouse IgG (5μg/mL, Elabscience, Wuhan, CN) to the culture medium. .. Following 24 hours of activation, the cell culture supernatant was collected, and the concentration of secreted IFN-γ was quantified using a Article Title: Knockdown of PELI1 promotes Th2 and Treg cell differentiation in juvenile idiopathic arthritis. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. |
![<t>Vectorized</t> <t>IFNβ</t> drives durable signaling and complete tumor regression in human glioblastoma models in vivo (A) Sustained hIFNβ secretion in human GBM6 cells treated with AAV9-hIFNβ (red, MOI = 4E5 vg/cell) or recombinant hIFNβ cytokine (r-hIFNβ, purple, 47 IU/mL, equivalent to 114 pg/mL), measured by ELISA at indicated time points. 50% media washouts every 5 h for the first 20 h in the r-hIFNβ condition mimic in vivo cytokine clearance (half-life = 4–5 h). Full media exchanges were performed at 24, 48, 72, and 96 h post-treatment. (B) Number of differentially expressed genes (DEGs, p -Adj<0.01) in GBM6 cells 24–96 h post-treatment with AAV9-hIFNβ or r-hIFNβ vs. media controls. (C) Enrichment scores for type I <t>IFN</t> and TNFα response pathways across treatments and time points. (D) Heatmap of the top 10 IFN and TNFα response genes (Log2FC vs. media controls) in GBM6 cells treated as in (A). (E) Schematic of orthotopic PDX (SF11411) and cell line-derived xenograft ([CDX], GBM6-FLuc) studies in athymic nu/nu mice treated intratumorally with saline, AAV9-GFP, or AAV9-hIFNβ via CED. (F) Kaplan-Meier survival curves for PDX mice treated as in (E). Saline = black, AAV9-GFP (2E11 vg/brain) = blue, AAV9-hIFNβ (2E11 vg/brain) = red. Vertical dashed line = day of treatment (day 9). p < 0.04 by log-rank (Mantel-Cox) test. n = 30 (10 per treatment arm). (G) Longitudinal BLI of GBM6-FLuc tumor growth in CDX mice treated as in (E). Saline = black, AAV9-GFP (2E11 vg/brain) = blue, AAV9-hIFNβ (2E11 vg/brain) = red. Thin lines = individual mice, thick lines = geometric mean. Vertical dashed line = day of treatment (day 9). ∗ p < 0.04 by Kruskal-Wallis test with Dunn’s multiple comparisons correction on day 22. n = 30 (10 per treatment arm). (G′) Representative BLI images from each treatment group 11 days post-treatment. (H) Kaplan-Meier survival curves for CDX mice. p < 0.001 by log-rank (Mantel-Cox) test. (I) Distribution of treatment responses in CDX by BLI flux (photons/second) at day 27. Tumor free = BLI flux <2.5 × 10 5 p/s, tumor reduction = ≥30% decrease from assignment on day 9, no change = between 30% decrease and 20% increase from assignment on day 9, tumor growth = ≥20% increase from assignment on day 9, death = mice that died before day 27. (J) Dose-response analysis of AAV9-hIFNβ efficacy in CDX mice. AAV9-GFP (2E11 vg/brain) = blue, AAV9-hIFNβ hi (2E11 vg/brain) = solid red, and AAV9-hIFNβ lo (1E11 vg/brain) = dashed red. Thin lines = individual mice, thick lines = geometric mean. Vertical dashed line = day of treatment (day 9). ∗∗ p < 0.02 by Kruskal-Wallis test with Dunn’s multiple comparisons correction on day 20. n = 45 (15 per treatment arm). For data interpretation, tumor burden threshold = 2.5 × 10 5 . (J′) Representative BLI images of tumors 11 days post-treatment. (K) Kaplan-Meier survival curves from (J). p < 0.002 (AAV9-hIFNβ hi), p < 0.005 (AAV9-hIFNβ lo) by log-rank (Mantel-Cox) test compared to AAV9-GFP. (I) Distribution of treatment responses in CDX mice at day 27 by BLI flux as in (I).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_1051/pmc13091051/pmc13091051__gr2.jpg)
